Reported Oct 3, 2018 · Terminated
Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway,…
Hetero Labs, Ltd. - Unit III
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Hetero Labs, Ltd. - Unit III · Plot 22-110, Part Ii, Ida · Hyderabad · N/A
Is this the product you have?
- Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only
- Manufactured forCamber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90
- Lot codes and dates
Lot #: E181370Exp. 5/2020
- Amount recalled
- 5,424 bottles
Where it was sold
Why it was recalled
Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Hetero Labs, Ltd. - Unit III recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.